Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier $4.9 billion deal and intensifying the race for dominance in the lucrative obesity drug market.
The National Guard deployment in Washington, D.C. has been extended through February 2026, raising concerns about the legality and cost of the federal intervention.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier $4.9 billion deal and intensifying the race for dominance in the lucrative obesity drug market.
The National Guard deployment in Washington, D.C. has been extended through February 2026, raising concerns about the legality and cost of the federal intervention.